PerkinElmer Acquires Avalon Instruments, Adding Raman Spectroscopy Capability; Highly Reproducible Results in an Easy-to-Use Bench-top Raman

BOSTON–Sept. 5, 2006–PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced the acquisition of Avalon Instruments Limited, based in Belfast, Northern Ireland. The acquisition expands and complements PerkinElmer’s Molecular Spectroscopy product portfolio through adding a family of innovative bench-top dispersive Raman spectrometers. The Avalon Raman platforms support both bulk analysis and microscopic imaging, enabling scientists and technicians to gain more information about their samples with excellent reproducibility. Terms of the deal were not disclosed. Raman spectroscopy identifies and characterizes the composition of both organic and inorganic materials in a wide range of applications. It is a complementary analysis technique to near infrared spectroscopy (NIR) and infrared spectroscopy (IR). Raman provides labs with the ability to analyze solids, liquids, powders, gels, slurries and aqueous solutions in bulk or to address variation in sample distribution with imaging. The technology is applicable to a diverse range of end markets, including pharmaceuticals, forensics and academia. “Customers will now have a single dependable source for high-throughput IR, NIR and Raman, along with integrated software and accessories,” said Robert F. Friel, president of PerkinElmer Life and Analytical Sciences. “The PerkinElmer Raman instrumentation is designed for intuitive use, minimal operator intervention, and highly reproducible results to help labs achieve a high level of throughput and productivity.” “We are excited to join PerkinElmer and contribute to their innovative approach to product development and continuous improvement, along with becoming part of a global leader in customer service and support,” said Dr. Andrew Dennis, managing director, Avalon Instruments. Factors Affecting Future Performance This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as “believes,” “intends,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) our failure to protect adequately our intellectual property; (4) the loss of any of our licenses or licensed rights; (5) our ability to compete effectively; (6) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (7) our ability to produce an adequate quantity of products to meet our customers’ demands; (8) our failure to maintain compliance with applicable government regulations; (9) regulatory changes; (10) economic, political and other risks associated with foreign operations; (11) our ability to retain key personnel; (12) restrictions in our credit agreement; (13) our ability to realize the full value of our intangible assets; and (14) other factors which we describe under the caption “Risk Factors” in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

< | >